Prostate cancer prevention with 5 alpha-reductase inhibitors

Dipen J. Parekh

Research output: Chapter in Book/Report/Conference proceedingChapter

3 Scopus citations


Testosterone gets converted into the more potent 5-[alpha]- dihydrotestosterone by 5-[alpha]- reductase. dihydrotestosterone (DHT) controls prostate mitotic activity and potentially prostate carcinogenesis. Interventions that inhibit 5-[alpha]-reductase have potential as preventive agents for prostate cancer.

Original languageEnglish (US)
Title of host publicationClinical Cancer Prevention
EditorsHans-Jorg Senn, Florian Otto
Number of pages6
StatePublished - 2011
Externally publishedYes

Publication series

NameRecent Results in Cancer Research
ISSN (Print)0080-0015

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Prostate cancer prevention with 5 alpha-reductase inhibitors'. Together they form a unique fingerprint.

Cite this